CD34 and type 2 diabetes mellitus: Taken together our observation of an increase in CD34+ EPCs and CD34+ CD184+ cells (Fig. 1) in linagliptin group are similar to the results from a recent study looking into the effects of linagliptin alone on EPCs in T2DM subjects [20].